XML 75 R59.htm IDEA: XBRL DOCUMENT
v3.19.3.a.u2

Equity-based compensation (Tables) | 12 Months Ended
--- | ---
Dec. 31, 2019
Share-Based Payment Arrangements [Abstract] |
Disclosure of number and weighted average exercise prices of other equity instruments | The below table summarizes unvested share movements for all Alcon equity-based incentive plans from the Spin-off through December 31, 2019:
| 2019
| Number of shares in thousand |  |  | Weighted average fair value at grant date in $ |  |  | Fair value in $ thousand |
Replacement awards issued at Spin-off(1) | 4,222 |  |  | n/a |  |  | 212,367 |
Granted |  |  |  |  |
Restricted awards | 625 |  |  | 56.1 |  |  | 35,037 |
Performance awards | 117 |  |  | 58.0 |  |  | 6,782 |
Vested(1) | (108 | ) |  | n/a |  |  | (5,432 | )
Forfeited(1) | (114 | ) |  | n/a |  |  | (5,734 | )
Unvested shares at December 31 | 4,742 |  |  | 51.2 |  |  | 243,020 |
(1) Based on estimated fair value per share at the time of Spin-off. The below table summarizes unvested share movements for all plans under the Former Parent for the year ended December 31, 2018 (Novartis AG RSAs, RSUs, and PSUs):
| 2018
| Number of shares in thousand |  |  | Weighted average fair value at grant date in $ |  |  | Fair value in $ thousand |
Unvested shares at January 1 | 2,800 |  |  | 74.4 |  |  | 208,300 |
Granted |  |  |  |  |
Annual incentive | 168 |  |  | 83.7 |  |  | 14,062 |
Share savings plans | 109 |  |  | 85.5 |  |  | 9,320 |
Select North America | 689 |  |  | 77.9 |  |  | 53,673 |
Select outside North America | 141 |  |  | 79.8 |  |  | 11,252 |
Long-Term Performance Plan | 316 |  |  | 88.4 |  |  | 27,934 |
Long-Term Relative Performance Plan | 37 |  |  | 51.2 |  |  | 1,894 |
Other share awards | 205 |  |  | 83.1 |  |  | 17,036 |
Vested | (814 | ) |  | 93.0 |  |  | (75,702 | )
Forfeited | (208 | ) |  | 80.4 |  |  | (16,723 | )
Unvested shares at December 31 | 3,443 |  |  | 72.9 |  |  | 251,046 |
Summary of shares authorized | The table below discloses the number of shares authorized under the plans as of December 31, 2019:
(thousands) | 2019 |
Long-term Incentive Plan | 20,000 |
Deferred Bonus Stock Plan | 1,500 |
Swiss Employee Share Ownership Plan | 475 |
Other share savings plans | 275 |
Authorized as of December 31, 2019 | 22,250 |
Disclosure of number and weighted average exercise prices of share options | The following table shows the activity associated with the Novartis AG share options during the year ended December 31, 2018. The weighted average prices in the table below are translated from Swiss francs into USD at historical rates.
| 2018
| Options (millions) |  |  | Weighted average exercise price ($) |  |  | Weighted average intrinsic value ($) |
Options outstanding at January 1 | 0.5 |  |  | 61.1 |  |  | 24.7 |
Sold or exercised | (0.1 | ) |  | 59.7 |  |  | 29.1 |
Outstanding at December 31 | 0.4 |  |  | 61.4 |  |  | 26.5 |
Exercisable at December 31 | 0.4 |  |  | 61.4 |  |  | 26.5 |
All Novartis AG share options were granted at an exercise price that was equal to the closing market price of the Novartis AG shares at the grant date. The weighted average Novartis AG share price at the dates of sale or exercise was $86.2. The following table summarizes information about Novartis AG share options outstanding at December 31, 2018:
| Options outstanding
Range of exercise prices($) | Number outstanding (thousand) |  |  | Average remaining contractual life (years) |  | Weighted average exercise price ($) |
45 - 55 | 32 |  |  | 0.7 |  | 52.4 |
56 - 66 | 394 |  |  | 3.5 |  | 62.1 |
Total | 426 |  |  | 3.3 |  | 61.4 |
Options under Novartis equity plan "Select" for North America The following table shows the activity associated with the Novartis AG American Depositary Receipts ("ADR") options during the period:
| 2018
| ADR options (millions) |  |  | Weighted average exercise price ($) |  |  | Weighted average intrinsic value ($) |
Options outstanding at January 1 | 1.8 |  |  | 62.5 |  |  | 21.4 |
Sold or exercised | (0.5 | ) |  | 62.4 |  |  | 25.8 |
Outstanding at December 31 | 1.3 |  |  | 62.6 |  |  | 23.2 |
Excercisable at December 31 | 1.3 |  |  | 62.6 |  |  | 23.2 |
All ADR options were granted at an exercise price that was equal to the closing market price of the ADRs at the grant date. The weighted average ADR price at the dates of sale or exercise was $81.4. The following table summarizes information about ADR options outstanding at December 31, 2018:
| ADR options outstanding
Range of exercise prices ($) | Number outstanding (thousand) |  |  | Average remaining contractual life (years) |  | Weighted average exercise price ($) |
45 - 55 | 30 |  |  | 0.6 |  | 50.7 |
56 - 66 | 1,258 |  |  | 3.6 |  | 62.9 |
Total | 1,288 |  |  | 3.5 |  | 62.6 |

X
- Definition Disclosure Of Detailed Information On Shares Authorised [Table Text Block] + References No definition available. + Details
Name: | alc_DisclosureOfDetailedInformationOnSharesAuthorisedTableTextBlock
Namespace Prefix: | alc_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Share-Based Payment Arrangements [Abstract] + References No definition available. + Details
Name: | alc_ShareBasedPaymentArrangementsAbstract
Namespace Prefix: | alc_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of the number and weighted average exercise prices of other equity instruments (ie other than share options). + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Name IFRS -Number 2 -IssueDate 2019-01-01 -Paragraph 45 -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2019-en-r&anchor=para_45&doctype=Standard -URIDate 2019-03-27 + Details
Name: | ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfOtherEquityInstrumentsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition The disclosure of the number and weighted average exercise prices of share options. [Refer: Weighted average [member]] + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Name IFRS -Number 2 -IssueDate 2019-01-01 -Paragraph 45 -Subparagraph b -URI http://eifrs.ifrs.org/eifrs/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2019-en-r&anchor=para_45_b&doctype=Standard -URIDate 2019-03-27 + Details
Name: | ifrs-full_DisclosureOfNumberAndWeightedAverageExercisePricesOfShareOptionsExplanatory
Namespace Prefix: | ifrs-full_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration